ArticleBlood cancer journal2026

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

Philipp Berning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.